SLN
Silence Therapeutics
SLN
SLN
64 hedge funds and large institutions have $588M invested in Silence Therapeutics in 2024 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
0.76% more ownership
Funds ownership: 19.11% → 19.87% (+0.76%)
Holders
64
Holding in Top 10
8
Calls
–
Puts
–
Top Buyers
| 1 | +$43.8M | |
| 2 | +$25.7M | |
| 3 | +$22.7M | |
| 4 |
NI
Nextech Invest
Zurich,
Switzerland
|
+$20.6M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$13.6M |
Top Sellers
| 1 | -$29.7M | |
| 2 | -$26.2M | |
| 3 | -$25.9M | |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$10.1M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$6.65M |